News
Treasury’s upsized buybacks may complicate Fed’s monetary policy work
Aug 20 (Reuters) - Federal Reserve Chairman Kevin Warsh has promised that the U.S. central bank will deliver...
- By Chloe Harper
- 20.08.2026
Trump warns of economic consequences for any country that supports Iran
WASHINGTON/DUBAI, Aug 20 (Reuters) - U.S. President Donald Trump warned of economic consequences against any country that provided...
- By Chloe Harper
- 20.08.2026
Coldcard theft: FBI may know 1,082 BTC attacker
Investigators may have given U.S. authorities information capable of identifying an attacker responsible for the first Coldcard theft...
- By Chloe Harper
- 19.08.2026
Morning Bid: Bond investors in revolt as Iran threatens to go ’fully offensive’
A look at the day ahead in European and global markets from Gregor Stuart Hunter
- By Chloe Harper
- 18.08.2026
Exclusive-Trump approval falls to 33%, lowest of his presidency, Reuters/Ipsos poll finds
WASHINGTON, Aug 17 (Reuters) - President Donald Trump’s approval rating fell to the lowest level of his presidency,...
- By Chloe Harper
- 18.08.2026
Blockchain Association urges SEC to drop 2 trading rules
The Blockchain Association urged the U.S. Securities and Exchange Commission to rescind two provisions of Regulation NMS, arguing...
- By Chloe Harper
- 18.08.2026
Australia’s BHP, unions fail to reach wage deal
Aug 18 (Reuters) - BHP Ports Unions said on Tuesday that it had failed to reach an agreement with BHP...
- By Chloe Harper
- 18.08.2026
Bitcoin hovers around $63k as Strategy’s Saylor calls it ‘digital monetary energy’
Bitcoin traded just under $63,000 on Sunday, as Strategy Chairman Michael Saylor argued in a post on X that the cryptocurrency...
- By Chloe Harper
- 17.08.2026
Morning Bid: Could consumers keep the Fed on hold, while Japan hikes?
Aug 17 (Reuters) - A look at the day ahead in European and global markets from Tom Westbrook
- By Chloe Harper
- 17.08.2026
Hutchmed shares rise 5% after positive Phase III lung cancer trial results
HUTCHMED China (HK:0013) shares rose on Monday after the drugmaker reported positive Phase III trial results for its...
- By Chloe Harper
- 17.08.2026
